| Prev Close | 84.78 |
| Open | 85.79 |
| Day Low/High | 85.33 / 86.08 |
| 52 Wk Low/High | 64.03 / 88.76 |
| Volume | 1.29M |
| Avg Volume | 4.98M |
Abbott Laboratories (ABT)
85.76
0.98
1.20
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 1.77B |
| Market Cap | 148.36B |
| EPS | 1.30 |
| P/E Ratio | 51.81 |
| Div & Yield | 1.28 (1.48%) |
Edward Jones: EMC, Devon Offer Growth Opportunities
The demand for storage is greater than ever due to increased regulatory requirements and internet usage, which is why EMC remains a stock worth owning.
Calling the Right Plays in 2014
Great investors and great quarterbacks have a lot in common.
Healthcare Holding Strong
It's clear that bulls in this sector aren't weak hands.
Abbott Labs Breaks Out
Bullish action has set the stock up well for more upside.
The Day Ahead: Full Speed Ahead
U.S. futures are positive to start first full week of 2014 trading.
Cramer: Too Much Negativity on Earnings
Update: Let's look at the big hits, not just the misses.
Earnings Look Good Through This Prism
This season isn't the drag it's made out to be.
The Day Ahead: Deal Hope Still There
UPDATE: Futures higher as Senate negotiations restart.
Early-Morning Market Look
Let's take a peek at overnight and early-morning price action in the major asset classes. Exit light Enter night Take my hand We're off to never never land. -- Metallica, "Enter Sandman" Let's take a peek at overnight and early-morning price action ...
Rules of the Game: Identifying Growth Stocks
The objective of investing is to offset future liabilities and manage risk.
Cramer Talks Abbott & Glaxo
TheStreet's Jim Cramer says Abbott Labs will benefit from growth in emerging markets and Glaxo will benefit from a "huge pipeline of approvals." The Action Alerts Plus portfolio recently bought Glaxo shares and added to their position in Abbott Labs.
Health Care Stocks Still Promising
Plenty of leadership remains in the health care sector and there's reason to see further potential.
Seven to Watch
Trading at 7x earnings, these stocks are all poised to outperform the market this year.
It's a Good Time to Buy All-Weather Laggards
Don't chase recent winners, search for stocks that have good 2013 prospects.
Market on Close Imbalances
How much to sell? My mavens on the floor see $1.6 billion to sell market on close, so my observation earlier in the afternoon might have had some merit. In terms of sectors, the largest to buy include health care ($ 85 ,million) and financials ($3...
Separating 'Facts' From 'Guidance'
Being behind the market or beating estimates isn't enough; guidance has to be good.
Chairman's Club Call Roundup
Markets would soar to all-time highs if our country's budget issues finally get resolved.
